Orchestra BioMed Holdings, Inc. (OBIO)
$5.95+3.84%Close
BUYBEAR · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $356M
- Beta
- 0.53
- P/E (TTM)
- -5.90
- Short % float
- 6.17%
- Days to cover
- 7.0
- SI change
- +7.4%
- 1W
- +0.00%
- 1M
- +2.41%
- vs SPY 1W
- -1.16%
- vs SPY 1M
- -0.58%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on OBIO?
- LOPJLB’s latest quantitative signal on Orchestra BioMed Holdings, Inc. (OBIO) is BUY in a BEAR regime. Signals are updated daily.
- What market regime is OBIO in?
- Orchestra BioMed Holdings, Inc. (OBIO) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Orchestra BioMed Holdings, Inc. (OBIO) do?
- Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for m…